Molina Healthcare, Inc.
NYSE:MOHMedical - Healthcare Plans
-$4.68 today
- Market cap
- $10.78B
- Beta
- 0.80
- P/E (TTM)
- 53.0
- EPS (TTM)
- $3.69
Volume 1.33M
Average 1.37M
MOH Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Molina Healthcare, Inc.NYSE: MOH
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures declines year over year
Q3 FY2026 capital expenditures of $37M (cash outflow) fell 2.6% year over year, ahead of the -17.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 23.3% from the prior quarter. Over 3 fiscal years it compounded at +3.5% a year.
Context
- Capital expenditures amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -2.6% holds above the trailing-twelve-month pace of -17.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (101M) USD
- Year-over-year change
- -1.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (101M) | -1.0% |
| FY2024 | 2024-12-31 | (100M) | -19.0% |
| FY2023 | 2023-12-31 | (84M) | +7.7% |
| FY2022 | 2022-12-31 | (91M) | -18.2% |
| FY2021 | 2021-12-31 | (77M) | — |
Capital Expenditures vs competitors
How MOH compares with its peers on the latest reported figures
- MOH's LTM Sep 2026 capital expenditures of $93M is the 6th largest of the 8 companies compared; the peer median is $798M.
- Its year-over-year change of -17.7% is the 7th highest of 8, against a peer median of -5.1%.
- Capital expenditures amounts to 0.2% of revenue for MOH, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.37B | -6.1% | +8.9% | 0.7% | |
| LTM Sep 2026 | $1.16B | -5.1% | -2.2% | 0.4% | |
| LTM Sep 2026 | $1.08B | -5.5% | -1.1% | 0.5% | |
| LTM Jun 2026 | $798M | +22.8% | -8.6% | 0.4% | |
| LTM Sep 2026 | $592M | +18.9% | -21.7% | 0.4% | |
| LTM Sep 2026 | $93M | -17.7% | +3.5% | 0.2% | |
| LTM Jun 2026 | $38.63M | +18.2% | +7.8% | 0.3% | |
| LTM Mar 2026 | $15.37M | -60.1% | +4.0% | 0.4% | |
| Peer median (excluding MOH) | $798M | -5.1% | -1.1% | 0.4% | |
Competitors are the stored peer set for MOH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 659M | 792M | 1.09B | 1.18B | 472M |
| Depreciation & Amortization | 131M | 176M | 171M | 186M | 195M |
| Deferred Income Tax | (24M) | (66M) | (31M) | 53M | 43M |
| Stock-Based Compensation | 72M | 103M | 115M | 116M | 47M |
| Change in Working Capital | 1.22B | (448M) | 314M | (898M) | (1.29B) |
| Accounts Receivables | (415M) | (95M) | (778M) | (78M) | (145M) |
| Inventory | 0 | 0 | 778M | 0 | 0 |
| Accounts Payables | 138M | 55M | 328M | 115M | (221M) |
| Other Working Capital | 1.5B | (408M) | (14M) | (935M) | (923M) |
| Other Non-Cash Items | 58M | 216M | 2M | 8M | (3M) |
| Operating Cash Flow | 2.12B | 773M | 1.66B | 644M | (535M) |
| Capital Expenditures | (77M) | (91M) | (84M) | (100M) | (101M) |
| Acquisitions (Net) | (129M) | (134M) | (3M) | (344M) | (245M) |
| Purchases of Investments | (2.71B) | (1.91B) | (1.43B) | (1.13B) | (751M) |
| Sales of Investments | 1.33B | 1.4B | 772M | 1.11B | 1.41B |
| Other Investing Activities | (63M) | (50M) | 4M | 1M | 1M |
| Investing Cash Flow | (1.65B) | (790M) | (744M) | (464M) | 312M |
| Debt Repayment | 17M | 0 | 0 | 740M | 838M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (128M) | (400M) | (60M) | (1B) | (1B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (19M) | (41M) | 2M | (87M) | (8M) |
| Financing Cash Flow | (183M) | (441M) | (58M) | (347M) | (170M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 283M | (458M) | 860M | (167M) | (393M) |
| Free Cash Flow | 2.04B | 682M | 1.58B | 544M | (636M) |
Molina Healthcare, Inc.
NYSE:MOH
Intrinsic Alpha fair value
Locked
Current Price
$206.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.